Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways

BACKGROUND: Targeted therapies are emerging treatment options for gastric cancer (GC). Patient-derived tumor xenograft(PDX) models of GC closely retain the features of the original clinical cancer, offering a powerful tool for preclinical drug efficacy testing. This study aimed to establish PDX GC m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haiyong, Lu, Jun, Tang, Jian, Chen, Shitu, He, Kuifeng, Jiang, Xiaoxia, Jiang, Weiqin, Teng, Lisong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348902/
https://www.ncbi.nlm.nih.gov/pubmed/28292264
http://dx.doi.org/10.1186/s12885-017-3177-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348902/
https://www.ncbi.nlm.nih.gov/pubmed/28292264
http://dx.doi.org/10.1186/s12885-017-3177-9

Ejemplares similares